Veterinary Medicines

Quiflor 20 mg/ml solution for injection for cattle, pigs and dogs

Not authorised
  • Marbofloxacin
Download as PDF

Product identification

Medicine name:
Quiflor 20 mg/ml Solution for Injection for Cattle, Pigs and Dogs
Quiflor 20 mg/ml solution for injection for cattle, pigs and dogs
Active substance:
  • Marbofloxacin
Target species:
  • Cattle (pre-ruminant)
  • Dog
  • Pig
Route of administration:
  • Intravenous use
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Marbofloxacin
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle (pre-ruminant)
      • Meat and offal
        6
        day
    • Dog
  • Subcutaneous use
    • Cattle (pre-ruminant)
      • Meat and offal
        6
        day
    • Dog
  • Intramuscular use
    • Cattle (pre-ruminant)
      • Meat and offal
        6
        day
    • Pig
      • Meat and offal
        4
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01MA93
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • United Kingdom (Northern Ireland)
Package description:
  • (ID4): 1 unspecified outer container with 1 Vial (Glass) with 20 millilitre(s) (20 millilitre(s))
  • (ID3): 1 unspecified outer container with 1 Vial (Glass) with 250 millilitre(s) (250 millilitre(s))
  • (ID2): 1 unspecified outer container with 1 Vial (Glass) with 100 millilitre(s) (100 millilitre(s))
  • (ID1): 1 unspecified outer container with 1 Vial (Glass) with 50 millilitre(s) (50 millilitre(s))

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • KRKA tovarna zdravil d.d. Novo mesto
Marketing authorisation date:
Manufacturing sites for batch release:
  • Krka d.d. Novo Mesto
  • Tad Pharma GmbH
Responsible authority:
  • The Veterinary Medicines Directorate
Authorisation number:
  • Vm01656/4060
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0301/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 14/02/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."